Why Is Micafungin (Mycamine) So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed micafungin (brand name Mycamine), you may have quickly discovered that this medication is not something you can pick up at your local drugstore. Micafungin is an intravenous (IV) antifungal medication, meaning it must be administered in a hospital, clinic, or through a specialty home infusion service. That alone sets it apart from most medications patients are used to managing, and it is a major reason access can feel difficult.

In this article, we break down exactly why micafungin can be hard to find, what the current supply situation looks like in 2026, and what steps you can take to make sure you get the treatment you need.

What Is Micafungin and Who Needs It?

Micafungin is an echinocandin antifungal drug used to treat and prevent serious Candida fungal infections. It was first approved by the FDA in 2005 for adults and has since been approved for children and even neonates under 4 months old. The brand name version, Mycamine, is manufactured by Astellas Pharma. Generic versions are now available from multiple manufacturers.

Patients who receive micafungin typically have serious conditions such as candidemia (Candida in the bloodstream), invasive Candida infections affecting organs, esophageal candidiasis, or are undergoing hematopoietic stem cell transplants (HSCT) and need prophylaxis. These are predominantly hospitalized or immunocompromised patients in ICUs, transplant units, or oncology wards.

Is There a Micafungin Shortage in 2026?

As of early 2026, micafungin is not listed on the FDA active drug shortage database. Multiple generic manufacturers now produce micafungin for injection, which has helped stabilize supply since branded Mycamine held a more exclusive market position. That said, availability can vary significantly depending on your care setting. Most major hospitals carry micafungin or can obtain it quickly as a standard formulary drug. Specialty and home infusion pharmacies vary in stock levels, and retail pharmacies generally do not stock it at all due to its IV formulation.

Why Is Micafungin Hard to Access Even Without a Shortage?

Even when micafungin is technically available, patients and caregivers often run into barriers. Here are the main reasons:

1. It Is an IV-Only Drug With No Oral Option

Unlike fluconazole, which has oral tablets, micafungin has no pill or capsule form. Every dose must be infused intravenously over approximately one hour. This means patients must either remain hospitalized, travel to an outpatient infusion center, or arrange home infusion services, each of which adds complexity and potential barriers.

2. It Is a Specialty Medication With Extra Access Steps

Micafungin is classified as a specialty medication. For outpatient use, patients may encounter insurance prior authorization requirements, specialty pharmacy routing, and coordination between physicians and pharmacy teams. These administrative hurdles can delay access by days, which is particularly dangerous when treating serious invasive fungal infections.

3. It Is Billed Under the Medical Benefit, Not the Pharmacy Benefit

Because micafungin is given by injection in a clinical setting, it is typically billed under your medical insurance benefit (like Medicare Part B) rather than through your pharmacy benefit (Part D). This creates confusion about coverage, unexpected billing, and out-of-pocket costs. Medicare co-insurance for micafungin is 20% under Part B.

4. Supply Chain Complexity for Sterile Injectables

Sterile injectable medications like micafungin require specialized manufacturing facilities with strict quality controls. Raw materials are sourced globally, and any disruption, whether a manufacturing quality issue, raw material shortage, or shipping delay, can quickly ripple through the supply chain. While micafungin is not currently in shortage, this category of drugs is historically vulnerable. Between 2022 and 2024, the average selling price of micafungin dropped by over 15%, reflecting growing generic competition but also tighter margins that could reduce manufacturer interest if demand softens.

5. Not All Specialty Pharmacies Carry It

For patients transitioning from hospital care to home infusion therapy, not every specialty pharmacy maintains micafungin in stock. Some require lead time to order the drug, which can cause dangerous gaps in treatment for serious fungal infections. When multiple manufacturers supply the market, hospitals and pharmacies may stock different brands, occasionally leading to localized availability gaps when a single supplier experiences delays.

What Can Patients and Caregivers Do?

Talk to your infectious disease physician or hospital care team immediately. They often have direct lines to hospital pharmacy contacts and can expedite access.

Ask about alternative echinocandins. Caspofungin and anidulafungin are in the same drug class and may be more readily available at certain facilities.

Contact multiple specialty pharmacies. If you are on home infusion, call ahead and ask specifically about micafungin 50 mg and 100 mg vial availability before committing to a provider.

Use medfinder — visit medfinder.com to find which pharmacies near you have micafungin in stock. medfinder contacts pharmacies on your behalf so you don't have to spend hours on hold.

Verify insurance coverage in advance. Ask your insurer whether micafungin requires prior authorization and which infusion providers are in-network.

What About Generic Micafungin?

Generic micafungin for injection is now available from multiple manufacturers, which has brought costs down significantly compared to branded Mycamine. Generic 50 mg vials start around $28 to $80, and 100 mg vials around $47 to $150, depending on the supplier and distribution channel. Hospitals typically purchase at negotiated contract prices that are lower than these retail estimates. The availability of generics is a positive development for access, though it also means localized availability gaps can occur when any one supplier experiences delays.

The Bottom Line

Micafungin is not hard to find because of a supply shortage in the traditional sense. It is hard to access because of the unique logistics of IV specialty medications. Understanding the system, communicating proactively with your care team, and using tools designed to locate specific medications can make all the difference.

For more practical help, read our guide on how to find micafungin in stock near you.